據沙特媒體哈達斯（Alhadath）：以色列在襲擊貝魯特南郊之前提前通知了美國。

AstraZeneca CEO Pascal Soriot warned that under terms of an agreement with the Trump administration to lower US patients' drug costs, the Anglo-Swedish drugmaker may be forced to suspend launching new drugs in the UK and Europe if it cannot secure higher drug prices. Soriot said European countries must increase funding for innovative medicines or AstraZeneca could concentrate almost entirely on the US market, which accounts for nearly half of its revenue.

China Galaxy Macro says May nonfarm payrolls beat expectations but do not imply the Fed will raise rates this year. May labor-market data remain overall stronger than expected, leaving the Fed without near-term evidence to justify a rate cut; at the same time the labor-market structure shows no clear acceleration that would trigger an inflationary spiral, so markets need not overprice an intra-year hike. Stronger nonfarm prints since March raise the bar for cuts but, in China Galaxy Macro’s view, do not create upward pressure to hike. The group considers markets have likely overestimated hike risk, though lagging economic releases cannot disprove that risk and the Fed remains data-dependent. After extreme AI-driven positioning, markets face a correction risk; liquidity normalization is expected to resume this year but timing is uncertain.